A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium
Roger L. Milne(The University of Melbourne), Petra Seibold(German Cancer Research Center), Christina A. Clarke(Menlo School), Jonathan P. Tyrer(University of Cambridge), Keith Humphreys(Stanford Medicine), Jingmei Li(Genome Institute of Singapore), Jenny Chang‐Claude(Universität Hamburg), Jan Lubiński(Tumour Institute of Tuscany), Anthony J. Swerdlow(Institute of Cancer Research), Joe Dennis(University of Cambridge), Mikael Eriksson(Herlev Hospital), Jesús Herránz(Madrid Institute for Advanced Studies), Anna González‐Neira(Spanish National Cancer Research Centre), Kamila Czene(Karolinska Institutet), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Irene L. Andrulis(University of Toronto), Anna Marie Mulligan, Henrik Flyger(University of Copenhagen), Anna Jakubowska(Pomeranian Medical University), Heli Nevanlinna(University of Helsinki), Susan L. Neuhausen(City of Hope), Carl Blomqvist(University of Helsinki), José Ignacio Arias Pérez, Argyrios Ziogas(University of Copenhagen), Stig E. Bojesen(University of Copenhagen), M. Pilar Zamora(Universidad Autónoma de Madrid), Hoda Anton‐Culver(University of California, Irvine), Anja Rudolph(Institut für Qualität im Management (Germany)), Børge G. Nordestgaard(Gentofte Hospital), Melissa C. Southey(The University of Melbourne), Julia A. Knight, Gillian S. Dite(University of Melbourne), Taru Muranen(Karolinska Institutet), Qin Wang(University of Cambridge), Katarzyna Durda(Pomeranian Medical University), Alan Ashworth(University of California, San Francisco), Kristiina Aittomäki(University of Helsinki), Hatef Darabi, John L. Hopper(The University of Melbourne), Gord Glendon, M. Rosario Alonso(Spanish National Cancer Research Centre), Katarzyna Jaworska–Bieniek(National University of Singapore), Carmel Apicella(The University of Melbourne), Minouk J. Schoemaker(Institute of Cancer Research), Manjeet K. Bolla(University of Cambridge), Guillermo Pita(Spanish National Cancer Research Centre)
Cited by 35
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k